Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Munro

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Diabetes, Obesity & Metabolism|October 14, 2022
Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studiesWilliam Hinton, Abdus Samad Ansari, Martin B Whyte, et al.
Diabetes Research and Clinical Practice|March 23, 2021
Diabetic retinopathy in newly diagnosed Type 2 diabetes mellitus: Prevalence and predictors of progression; a national primary network studySavan Shah, Michael Feher, Andrew McGovern, et al.
Plos Medicine|October 8, 2019
Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysisMartin B Whyte, William Hinton, Andrew McGovern, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 9, 2020
Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolismWilliam Hinton, Banne Nemeth, Simon de Lusignan, et al.
Diabetes, Obesity & Metabolism|April 4, 2022
Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort studyMartin B Whyte, Mark Joy, William Hinton, et al.
Primary Care Diabetes|June 20, 2021
Dashboards to reduce inappropriate prescribing of metformin and aspirin: A quality assurance programme in a primary care sentinel networkSimon de Lusignan, William Hinton, Samuel Seidu, et al.
The Science of the Total Environment|April 11, 2014
Environmental conditions and human drivers for changes to north Ethiopian mountain landscapes over 145 yearsJan Nyssen, Amaury Frankl, Mitiku Haile, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 1, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods StudySimon de Lusignan, Andrew McGovern, William Hinton, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2024
A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care populationAnna K Forbes, William Hinton, Michael D Feher, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|October 14, 2022
Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studiesWilliam Hinton, Abdus Samad Ansari, Martin B Whyte, et al.
Diabetes Research and Clinical Practice|March 23, 2021
Diabetic retinopathy in newly diagnosed Type 2 diabetes mellitus: Prevalence and predictors of progression; a national primary network studySavan Shah, Michael Feher, Andrew McGovern, et al.
Plos Medicine|October 8, 2019
Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysisMartin B Whyte, William Hinton, Andrew McGovern, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 9, 2020
Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolismWilliam Hinton, Banne Nemeth, Simon de Lusignan, et al.
Diabetes, Obesity & Metabolism|April 4, 2022
Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort studyMartin B Whyte, Mark Joy, William Hinton, et al.
Primary Care Diabetes|June 20, 2021
Dashboards to reduce inappropriate prescribing of metformin and aspirin: A quality assurance programme in a primary care sentinel networkSimon de Lusignan, William Hinton, Samuel Seidu, et al.
The Science of the Total Environment|April 11, 2014
Environmental conditions and human drivers for changes to north Ethiopian mountain landscapes over 145 yearsJan Nyssen, Amaury Frankl, Mitiku Haile, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 1, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods StudySimon de Lusignan, Andrew McGovern, William Hinton, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2024
A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care populationAnna K Forbes, William Hinton, Michael D Feher, et al.
Pageof 6